These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 16020180)

  • 1. Risk assessment for benefits analysis: framework for analysis of a thyroid-disrupting chemical.
    Axelrad DA; Baetcke K; Dockins C; Griffiths CW; Hill RN; Murphy PA; Owens N; Simon NB; Teuschler LK
    J Toxicol Environ Health A; 2005 Jun 11-25; 68(11-12):837-55. PubMed ID: 16020180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the potential impact of benchmark dose and pharmacokinetic modeling in noncancer risk assessment.
    Clewell HJ; Gentry PR; Gearhart JM
    J Toxicol Environ Health; 1997 Dec; 52(6):475-515. PubMed ID: 9397182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linking economics and risk assessment.
    Dockins C; Griffiths CW; Owens N; Simon NB; Axelrad DA
    J Toxicol Environ Health A; 2004 Apr 23-May 28; 67(8-10):611-20. PubMed ID: 15192857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acrylamide: review of toxicity data and dose-response analyses for cancer and noncancer effects.
    Shipp A; Lawrence G; Gentry R; McDonald T; Bartow H; Bounds J; Macdonald N; Clewell H; Allen B; Van Landingham C
    Crit Rev Toxicol; 2006; 36(6-7):481-608. PubMed ID: 16973444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of juvenile animal studies to determine the human effects and risks of environmental toxicants during postnatal developmental stages.
    Brent RL
    Birth Defects Res B Dev Reprod Toxicol; 2004 Oct; 71(5):303-20. PubMed ID: 15505806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The benchmark dose method--review of available models, and recommendations for application in health risk assessment.
    Filipsson AF; Sand S; Nilsson J; Victorin K
    Crit Rev Toxicol; 2003; 33(5):505-42. PubMed ID: 14594105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What to do at low doses: a bounding approach for economic analysis.
    Griffiths CW; Dockins C; Owens N; Simon NB; Axelrad DA
    Risk Anal; 2002 Aug; 22(4):679-88. PubMed ID: 12224742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistics for risk assessment of chemical carcinogens.
    Chen JJ; Chen YJ; Cheng KF
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2007; 25(4):281-312. PubMed ID: 18000784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of transcriptional benchmark dose values in quantitative cancer and noncancer risk assessment.
    Thomas RS; Clewell HJ; Allen BC; Wesselkamper SC; Wang NC; Lambert JC; Hess-Wilson JK; Zhao QJ; Andersen ME
    Toxicol Sci; 2011 Mar; 120(1):194-205. PubMed ID: 21097997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-cancer risk assessment for nickel compounds: issues associated with dose-response modeling of inhalation and oral exposures.
    Haber LT; Allen BC; Kimmel CA
    Toxicol Sci; 1998 Jun; 43(2):213-29. PubMed ID: 9710963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human milk biomonitoring data: interpretation and risk assessment issues.
    LaKind JS; Brent RL; Dourson ML; Kacew S; Koren G; Sonawane B; Tarzian AJ; Uhl K
    J Toxicol Environ Health A; 2005 Oct; 68(20):1713-69. PubMed ID: 16176917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Future of toxicology--low-dose toxicology and risk--benefit analysis.
    Rietjens IM; Alink GM
    Chem Res Toxicol; 2006 Aug; 19(8):977-81. PubMed ID: 16918235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research strategy for developing key information on bromate's mode of action.
    Bull RJ; Cottruvo JA
    Toxicology; 2006 Apr; 221(2-3):135-44. PubMed ID: 16298034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addressing nonlinearity in the exposure-response relationship for a genotoxic carcinogen: cancer potency estimates for ethylene oxide.
    Kirman CR; Sweeney LM; Teta MJ; Sielken RL; Valdez-Flores C; Albertini RJ; Gargas ML
    Risk Anal; 2004 Oct; 24(5):1165-83. PubMed ID: 15563286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approaches to extrapolating animal toxicity data on organic solvents to public health.
    Bushnell PJ; Boyes WK; Shafer TJ; Bale AS; Benignus VA
    Neurotoxicology; 2007 Mar; 28(2):221-6. PubMed ID: 16684563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health risk of low-dose pesticides mixtures: a review of the 1985-1998 literature on combination toxicology and health risk assessment.
    Carpy SA; Kobel W; Doe J
    J Toxicol Environ Health B Crit Rev; 2000; 3(1):1-25. PubMed ID: 10711323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
    Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
    Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.